UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Liver Transplantation for Cholangiocarcinoma

Not Applicable

Terminated

Conditions: Cancer
Cholangiocarcinoma
Liver

Interventions: Procedure: Liver Transplantation

First Posted Date: 2008-07-02

Last Posted Date: 2013-07-30

Lead Sponsor: University of Utah

Target Recruit Count: 5

Registration Number: NCT00708877

Locations: 🇺🇸
University of Utah/Huntsman Cancer Institute, Salt Lake City, Utah, United States

Moderate Sedation Educational Software

Terminated

Conditions: Moderate Sedation Training

Interventions: Behavioral: web based training
Behavioral: paper based training

First Posted Date: 2008-07-02

Last Posted Date: 2023-04-18

Lead Sponsor: University of Utah

Target Recruit Count: 38

Registration Number: NCT00708760

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Phase 1

Terminated

Conditions: Cancer
Chronic Myelomonocytic Leukemia

Interventions: Drug: Clofarabine

First Posted Date: 2008-07-02

Last Posted Date: 2017-06-01

Lead Sponsor: University of Utah

Target Recruit Count: 11

Registration Number: NCT00708721

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea

Not Applicable

Completed

Conditions: Hypercapnia

Interventions: Device: Quick Emergence Device
Other: standard of care for phase one anesthesia care

First Posted Date: 2008-07-02

Last Posted Date: 2022-11-29

Lead Sponsor: University of Utah

Target Recruit Count: 22

Registration Number: NCT00708526

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

Not Applicable

Completed

Conditions: Cancer
Lentigo Maligna

Interventions: Drug: Tazarotene Cream 0.1%
Drug: Imiquimod Cream

First Posted Date: 2008-06-30

Last Posted Date: 2013-07-31

Lead Sponsor: University of Utah

Target Recruit Count: 90

Registration Number: NCT00707174

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

Phase 2

Completed

Conditions: Cancer
Brain Cancer
Meningioma

Interventions: Drug: Hydroxyurea
Drug: Verapamil

First Posted Date: 2008-06-30

Last Posted Date: 2017-04-13

Lead Sponsor: University of Utah

Target Recruit Count: 8

Registration Number: NCT00706810

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors

Phase 1

Completed

Conditions: Cancer
Brain Tumors

Interventions: Radiation: FLT-PET Imaging

First Posted Date: 2008-06-30

Last Posted Date: 2021-10-15

Lead Sponsor: University of Utah

Target Recruit Count: 15

Registration Number: NCT00707343

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

Phase 1

Terminated

Conditions: Cancer

Interventions: Drug: [18F]fluoro-2-deoxy-D-glucose (FDG)

First Posted Date: 2008-06-30

Last Posted Date: 2022-04-27

Lead Sponsor: University of Utah

Target Recruit Count: 19

Registration Number: NCT00707213

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

Phase 2

Terminated

Conditions: Cancer
Melanoma

Interventions: Radiation: Radiation Therapy
Drug: Cisplatin
Procedure: Surgical resection

First Posted Date: 2008-06-30

Last Posted Date: 2017-03-31

Lead Sponsor: University of Utah

Target Recruit Count: 6

Registration Number: NCT00707161

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸
LDS Hospital, Salt Lake City, Utah, United States

Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma

Phase 1

Completed

Conditions: Cancer
Pancreas

Interventions: Radiation: Radiation Therapy
Drug: Capecitabine
Drug: Oxaliplatin

First Posted Date: 2008-06-30

Last Posted Date: 2014-10-31

Lead Sponsor: University of Utah

Target Recruit Count: 13

Registration Number: NCT00707278

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy